On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read more.
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for the prevention…
On Feb. 17, the U.S. Food and Drug Administration (FDA) announced the approval of Korlym (mifepristone) to control hyperglycemia in adults with endogenous Cushing’s…
A multicenter study of 28 surgeons performing 3,574 thyroidectomies published in BMJ found that surgeons aged between 35 and 50 years provide the safest…
Both of these complex endocrine disorders involve the adrenal glands and cause abnormal cortisol levels. Based on physical and laboratory findings, could you determine…
The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and high cholesterol…
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for…
Both of these complex endocrine disorders involve the adrenal glands and cause abnormal cortisol levels. Based on physical and laboratory findings, could…